Area of research
Molecular Biology · Pharmacology
Research interest
Research interests include Metabolomics and Mass Spectrometry Studies, Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, and Cancer, Hypoxia, and Metabolism.
Bile salt hydrolase catalyses formation of amine-conjugated bile acids
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis
Myelocytomatosis‐Protein Arginine N‐Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma
Metabolic map of the antiviral drug podophyllotoxin provides insights into hepatotoxicity
Comprehensive analysis of transcriptomics and metabolomics to understand triptolide-induced liver injury in mice
Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6
Metabolic alterations in triptolide‐induced acute hepatotoxicity
Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis
An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling
Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells